Clinical trial
An Exploratory, Multi-centre, Two-part Study to Describe Chronic Induced Urticaria Characteristics and Explore Novelbiomarkers With a Multimodal Patient Profiling Approach by Comparing CIndU Patients to Chronic Spontaneousurticaria Patients and Healthy Volunteers
NCT07359430 is registered in ClinicalTrials.gov with Centre for Human Drug Research, Netherlands as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory, Multi-centre, Two-part Study to Describe Chronic Induced Urticaria Characteristics and Explore Novelbiomarkers With a Multimodal Patient Profiling Approach by Comparing CIndU Patients to Chronic Spontaneousurticaria Patients and Healthy Volunteers
- Lead sponsor
- Centre for Human Drug Research, Netherlands
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 21, 2025
- Completion date
- June 1, 2026
- Enrollment
- 40 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
angio-oedema and/or urticaria, skin diseases